Hypertensive nephropathy epidemiology and demographics
Hypertensive nephropathy Microchapters |
Differentiating Hypertensive Nephropathy from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Hypertensive nephropathy epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Hypertensive nephropathy epidemiology and demographics |
FDA on Hypertensive nephropathy epidemiology and demographics |
CDC on Hypertensive nephropathy epidemiology and demographics |
Hypertensive nephropathy epidemiology and demographics in the news |
Blogs on Hypertensive nephropathy epidemiology and demographics |
Risk calculators and risk factors for Hypertensive nephropathy epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]
Overview
The incident counts and adjusted rates for hypertensive renal disease has been increasing gradually over the past three decades. 25,000 new cases of chronic renal failure attributable to high blood pressure, are diagnosed every year in the US. It has also contributed significantly to increase in the number of patients undergoing dialysis from renal insufficiency.
Epidemiology and Demographics
Prevalence
- More than 20% of patients with systemic hypertension have chronic renal insufficiency.
- The prevalence of hypertensive nephropathy among those with hypertension is 24.6%.
- The rate of end stage renal disease due to hypertension, while down 2.2 % in 2010, is 7.7 % higher than that in the year 2000.
Age
- Hypertensive renal disease has a higher prevalence in those aged 65 years and older.
Race
- The prevalence of hypertensive nephropathy is higher in African Americans.